Veterinary Medicine Information website

Enrotron 100 mg/ml oral solution for chicken and turkeys

Authorised
  • Enrofloxacin
Download as PDF

Product identification

Medicine name:
Enrotron 100 mg/ml oral solution for chicken and turkeys
Active substance:
  • Enrofloxacin
Target species:
  • Turkey
  • Rabbit
  • Chicken
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Enrofloxacin
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for use in drinking water
Withdrawal period by route of administration:
  • In drinking water use
    • Turkey
      • Meat and offal
        13
        day
    • Rabbit
      • Meat and offal
        15
        day
    • Chicken
      • Meat and offal
        7
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Available in:
  • Netherlands
Package description:
  • Cardboard box containing 6 x 1000 ml opaque polyethylene bottle with opaque polyethylene tamper evident screw cap and polypropylene measuring pitcher.
  • Cardboard box containing 12 x 100 ml opaque polyethylene bottle with opaque polyethylene tamper evident screw cap and polypropylene measuring pitcher.
  • 1000 ml opaque polyethylene bottle with opaque polyethylene tamper evident screw cap and polypropylene measuring pitcher
  • Cardboard box containing 100 ml opaque polyethylene bottle with opaque polyethylene tamper evident screw cap and polypropylene measuring pitcher.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • aniMedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • aniMedica GmbH
  • Industrial Veterinaria S.A.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 110981
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0165/003
Concerned member states:
  • Cyprus
  • France
  • Germany
  • Ireland
  • Poland
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 24/01/2022
Download